Gary Finnegan

Deal paves the way for outcomes-based drug pricing

An agreement between the pharma industry and health care providers in Manchester will collect real-world data on the value of drugs. The aim is to open the door to fixing drug prices based on how effective they are in everyday use
02 Mar 2017

EMPTY

A series of pilot projects will use patient outcomes to inform funding decisions, initiating a move from activity-based to value-based healthcare
12 Dec 2016